Hiroshi Onogi

1.4k total citations
16 papers, 1.2k citations indexed

About

Hiroshi Onogi is a scholar working on Molecular Biology, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Hiroshi Onogi has authored 16 papers receiving a total of 1.2k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 3 papers in Epidemiology and 2 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Hiroshi Onogi's work include RNA Research and Splicing (9 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). Hiroshi Onogi is often cited by papers focused on RNA Research and Splicing (9 papers), RNA modifications and cancer (3 papers) and RNA and protein synthesis mechanisms (3 papers). Hiroshi Onogi collaborates with scholars based in Japan, United States and Ireland. Hiroshi Onogi's co-authors include Masatoshi Hagiwara, Takamitsu Hosoya, Takashi Wakabayashi, Adrian R. Krainer, Hiroshi Shibuyà, Nobutoshi Ito, Yoshichika Okamoto, Isao Kii, Toshiyuki Hiramatsu and Akila Mayeda and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Hiroshi Onogi

16 papers receiving 1.1k citations

Peers

Countries citing papers authored by Hiroshi Onogi

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Onogi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Onogi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Onogi more than expected).

Fields of papers citing papers by Hiroshi Onogi

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Onogi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Onogi. The network helps show where Hiroshi Onogi may publish in the future.

Co-authorship network of co-authors of Hiroshi Onogi

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Onogi. A scholar is included among the top collaborators of Hiroshi Onogi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Onogi. Hiroshi Onogi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

16 of 16 papers shown

#	Work	Indexed citations
1	Bioluminescent immunoassay for serine/threonine protein kinase activity using an aequorin-labeled monoclonal antibody and a synthetic peptide as a substrate 2023 ·Biochemical and Biophysical Research Communications ·(unknown), Hiroshi Onogi, Namiko Nomura, Masatoshi Hagiwara, S Inouye	1
2	S1PR3–G12-biased agonist ALESIA targets cancer metabolism and promotes glucose starvation 2021 ·Cell chemical biology ·(unknown), Asuka Inoue, Kei Iida, (unknown), Isao Kii, Francois Marie Ngako Kadji, Takayuki Kishi, Dohyun Im, Tatsuro Shimamura, Hiroshi Onogi, Suguru Yoshida, So Iwata, Junken Aoki, Takamitsu Hosoya, Masatoshi Hagiwara	6
3	CDK9 Inhibitor FIT-039 Suppresses Viral Oncogenes E6 and E7 and Has a Therapeutic Effect on HPV-Induced Neoplasia 2018 ·Clinical Cancer Research ·Masahiko Ajiro, Hiroyuki Sakai, Hiroshi Onogi, Makoto Yamamoto, Eriko Sumi, (unknown), Takashi Nomura, Kenji Kabashima, Takamitsu Hosoya, Masatoshi Hagiwara	30
4	Rectifier of aberrant mRNA splicing recovers tRNA modification in familial dysautonomia 2015 ·Proceedings of the National Academy of Sciences ·Mayumi Yoshida, Naoyuki Kataoka, Kenjyo Miyauchi, Kenji Ohe, Kei Iida, Suguru Yoshida, Takayuki Nojima, Yukiko Okuno, Hiroshi Onogi, (unknown), Akihide Takeuchi, Takamitsu Hosoya, Tsutomu Suzuki, Masatoshi Hagiwara	83
5	CDK9 inhibitor FIT-039 prevents replication of multiple DNA viruses 2014 ·Journal of Clinical Investigation ·Makoto Yamamoto, Hiroshi Onogi, Isao Kii, Suguru Yoshida, Kei Iida, Hiroyuki Sakai, Minako Abe, Toshiaki Tsubota, Nobutoshi Ito, Takamitsu Hosoya, Masatoshi Hagiwara	66
6	The Kinase Inhibitor SFV785 Dislocates Dengue Virus Envelope Protein from the Replication Complex and Blocks Virus Assembly 2011 ·PLoS ONE ·Azlinda Anwar, Takamitsu Hosoya, (unknown), Hiroshi Onogi, Yukiko Okuno, Toshiyuki Hiramatsu, Hiroko Koyama, Masaaki Suzuki, Masatoshi Hagiwara, Mariano A. García-Blanco	34
7	Development of a novel selective inhibitor of the Down syndrome-related kinase Dyrk1A 2010 ·Nature Communications ·Yasushi Ogawa, Yosuke Nonaka, Toshiyasu Goto, Eriko Ohnishi, Toshiyuki Hiramatsu, Isao Kii, (unknown), Teikichi Ikura, Hiroshi Onogi, Hiroshi Shibuyà, Takamitsu Hosoya, Nobutoshi Ito, Masatoshi Hagiwara	229
8	Inhibition of Hepatitis C Virus Replication by a Specific Inhibitor of Serine-Arginine-Rich Protein Kinase 2010 ·Antimicrobial Agents and Chemotherapy ·(unknown), Naoya Sakamoto, Yasuhiro Itsui, Mina Nakagawa, Megumi Tasaka‐Fujita, Yuki Nishimura‐Sakurai, Sei Kakinuma, (unknown), Seishin Azuma, Kiichiro Tsuchiya, Hiroshi Onogi, Masatoshi Hagiwara, Mamoru Watanabe	48
9	Regulation of Binding of Lamin B Receptor to Chromatin by SR Protein Kinase and cdc2 Kinase in Xenopus Egg Extracts 2004 ·Journal of Biological Chemistry ·Makoto Takano, (unknown), Hiromi Ito, Satomi Hoshino, Hiroshi Onogi, Masatoshi Hagiwara, Kazuhiro Furukawa, Tsuneyoshi Horigome	47
10	Manipulation of Alternative Splicing by a Newly Developed Inhibitor of Clks 2004 ·Journal of Biological Chemistry ·Michiko Muraki, Bisei Ohkawara, Takamitsu Hosoya, Hiroshi Onogi, (unknown), Tomonobu Koizumi, Kengo Sumi, (unknown), Michael V. Murray, Hiroshi Kimurâ, Kiyoshi Furuichi, Hiroshi Shibuyà, Adrian R. Krainer, Masaaki Suzuki, Masatoshi Hagiwara	242
11	Novel SR-rich-related Protein Clasp Specifically Interacts with Inactivated Clk4 and Induces the Exon EB Inclusion of Clk 2002 ·Journal of Biological Chemistry ·(unknown), Hiroshi Onogi, Kazuhiro Wada, Yasushi Kawaguchi, Masatoshi Hagiwara	16
12	Cloning of Human PRP4 Reveals Interaction with Clk1 2001 ·Journal of Biological Chemistry ·(unknown), Takeru Zama, Kazuhiro Wada, Hiroshi Onogi, Masatoshi Hagiwara	55
13	The Subcellular Localization of SF2/ASF Is Regulated by Direct Interaction with SR Protein Kinases (SRPKs) 1999 ·Journal of Biological Chemistry ·(unknown), Yoshichika Okamoto, Hiroshi Onogi, Akila Mayeda, Adrian R. Krainer, Masatoshi Hagiwara	119
14	Dymple, a Novel Dynamin-like High Molecular Weight GTPase Lacking a Proline-rich Carboxyl-terminal Domain in Mammalian Cells 1998 ·Journal of Biological Chemistry ·Takahiro Kamimoto, Yasuo Nagai, Hiroshi Onogi, Yoshinao Muro, Takashi Wakabayashi, Masatoshi Hagiwara	49
15	cdc2 Kinase-Mediated Phosphorylation of Splicing Factor SF2/ASF 1998 ·Biochemical and Biophysical Research Communications ·Yoshichika Okamoto, Hiroshi Onogi, Reiko Honda, Hideyo Yasuda, Takashi Wakabayashi, Yuji Nimura, Masatoshi Hagiwara	30
16	Novel SR-Protein-Specific Kinase, SRPK2, Disassembles Nuclear Speckles 1998 ·Biochemical and Biophysical Research Communications ·(unknown), Hiroshi Onogi, Takashi Wakabayashi, Masatoshi Hagiwara	100

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact